Trending...
- RAS AP Consulting Expands AP Governance & Automation Practice and Named Finalist for Heidelberg Materials SAP Vendor & Customer Data Project - 108
- OneVizion Names AI Leader Matthew Kirk as Chief Operating Officer to Drive Governed AI Across Telecom and Electric Utilities
- Wagga Trucks set to expand to the Canberra Region as authorised dealer for Volvo, UD & Mack along with Freighter Group Trailers
CCHR's New Report Exposes Dangerous Neurological Interventions Being Pushed on Veterans, Children, and the Vulnerable
LOS ANGELES - ncarol.com -- The Citizens Commission on Human Rights International (CCHR), a leading mental health industry watchdog, has released a damning report detailing how psychiatry is blaming patients—rather than failed treatments—to justify a surge in brain stimulation interventions. "When psychiatric drugs and therapy don't work, psychiatry rarely blames the treatment—it blames the patient, saying they are 'treatment-resistant,'" said Jan Eastgate, President of CCHR International. "'Treatment-resistant' isn't a diagnosis—it's a deflection. And it's being used to push invasive procedures like Electroconvulsive Therapy (ECT), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), and Transcranial Magnetic Stimulation (TMS)."
These brain stimulation devices were "cleared" by the Food and Drug Administration (FDA) or approved under Humanitarian Device Exemptions, bypassing the rigorous testing normally required of most medical devices. Many were greenlighted based on the device delivering ECT—a practice known for causing brain damage, memory loss, and even death[1].
Even industry insiders acknowledge concerns. "The precise physiological mechanisms of DBS are not yet fully understood," admits one clinical review.[2] A professor of psychiatry at Brown University's Alpert Medical School, put it more starkly: "This really is a kind of mind control."[3]
The term "treatment-resistant" is a psychiatric sleight of hand, Eastgate says, now used to justify a global neurostimulation industry projected to hit $51 billion by 2030. Labeling up to 60% of psychiatric patients as "resistant" creates a false pretext for experimental interventions.[4] Meanwhile, 25% of patients develop psychotropic drug tolerance within weeks, prompting ever-riskier "solutions."[5]
Electroshock: Psychiatry's Recycled Blunder
ECT involves sending up to 460 volts through the brain to trigger seizures. Contrary to PR spin, Eastgate says, experts report modern ECT is no safer—voltage levels are higher than when broken bones were common due to convulsions.
Deep Brain Stimulation: Electrodes are surgically implanted into the brain, powered by a device in the chest.
Vagus Nerve Stimulation: Electrical stimulation delivered via electrodes wrapped around the vagus nerve.
Transcranial Magnetic Stimulation: Magnetic pulses are aimed at the brain over six weeks.
Despite the sophistication of these procedures, there is still no objective medical test to diagnose any psychiatric disorder. No blood test. No brain scan. No biomarker.[15]
More on ncarol.com
Dr. Thomas Insel, former director of the National Institute for Mental Health advised: "Unlike our definitions of ischemic heart disease, lymphoma, or AIDS, the DSM [Diagnostic and Statistical Manual of Mental Disorders] diagnoses are based on a consensus… not any objective laboratory measure."[16]
"It's not the patient that's resistant—it's the system that's resistant to accountability," Eastgate said. "In any other field, if the intervention failed, the treatment would be reevaluated. But psychiatry doubles down, pushing more dangerous interventions instead."
CCHR urges policy makers to: End all use of ECT and brain stimulation devices for treatment of mental issues, and end ECT's role as a predicate device for newer technologies. And support humane, non-invasive, non-drug, non-brain stimulation solutions that respect patient dignity and avoid neurological and other physical harm.
CCHR, established in 1969 by the Church of Scientology and psychiatrist Dr. Thomas Szasz has a record of reforms that include banning lethal Deep Sleep Treatment, outlawing ECT use on children in several U.S. states, and securing global recognition for patient rights. Today, the United Nations and WHO echo what CCHR has long fought for: coercion has no place in mental health care.
Sources:
[1] FDA, Final Rule on Electroconvulsive Therapy Devices, Federal Register, Dec. 26, 2018; WHO-OHCHR, "Guidance on Mental Health, Human Rights and Legislation," 9 Oct. 2023, p. 58, www.ohchr.org/sites/default/files/documents/publications/WHO-OHCHR-Mental-health-human-rights-and-legislation_web.pdf
[2] Lavanya P. Sharma, et. al, "Deep brain stimulation – A primer for psychiatrists," Asian Journal of Psychiatry, Vol. 104, Feb. 2025
[3] Lavanya P. Sharma, et. al, "Deep brain stimulation – A primer for psychiatrists," Asian Journal of Psychiatry, Vol. 104, Feb. 2025
[4] "Treatment resistance in psychiatry: state of the art and new directions," Mol Psychiatry, July 2021, pmc.ncbi.nlm.nih.gov/articles/PMC8960394/#fn-group1
[5] pmc.ncbi.nlm.nih.gov/articles/PMC9332474/
[6] WHO- OHCHR, "Guidance on Mental Health, Human Rights and Legislation," 9 Oct. 2023, pp. 15, 58 and 59; www.cchrint.org/2023/09/18/who-guideline-condemns-coercive-psychiatric-practices/
[7] "Electroconvulsive Shock Therapy Lawsuit – What You Should Know About ECT," www.wisnerbaum.com/defective-medical-device-injuries/ect/
[8] www.cchrint.org/2024/11/08/veterans-day-cchr-calls-for-safeguards/, Peter Simons, "ECT Does Not Seem to Prevent Suicide," Mad In America, 17 Feb. 2023, www.madinamerica.com/2023/02/ect-does-not-seem-to-prevent-suicide/
More on ncarol.com
[9] www.cchrint.org/2024/08/23/the-collapse-of-electroshock/ Based on Freedom of Information Requests to 27 states
[10] www.cchrint.org/2018/10/12/veterans-get-damaging-mental-health-deal/; Tricare Encounter Data (TED) Non-Institutional (Outpatient) for Purchased Care claims, Data Extract as of 10/21/2016, Data received from CCHR International Freedom of Information Request, 2016
[11] "Brain Stimulation Therapies," NIMH, www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies.shtml, accessed 21 Feb. 2011; Dr. Ananya Mandal, MD, "Deep Brain Stimulation Side Effects," News Medical Life Sciences, 22 July 2023, www.news-medical.net/health/Deep-Brain-Stimulation-Side-Effects.aspx
[12] Danielle Egan, "Adverse Effects: The Perils of Deep Brain Stimulation for Depression," Mad in America, 24 Sept. 2015
[13] www.hg.org/legal-articles/patients-with-complications-from-cyberonics-vns-therapy-systems-may-qualify-to-file-a-lawsuit-49467
[14] FDA MAUDE report, Neurostar TMS, 07/14/2021, www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/detail.cfm?mdrfoi__id=15283600&pc=OBP
[15] www.sciencedaily.com/releases/2020/08/200817104247.htm
[16] psychrights.org/2013/130429NIMHTransformingDiagnosis.htm
These brain stimulation devices were "cleared" by the Food and Drug Administration (FDA) or approved under Humanitarian Device Exemptions, bypassing the rigorous testing normally required of most medical devices. Many were greenlighted based on the device delivering ECT—a practice known for causing brain damage, memory loss, and even death[1].
Even industry insiders acknowledge concerns. "The precise physiological mechanisms of DBS are not yet fully understood," admits one clinical review.[2] A professor of psychiatry at Brown University's Alpert Medical School, put it more starkly: "This really is a kind of mind control."[3]
The term "treatment-resistant" is a psychiatric sleight of hand, Eastgate says, now used to justify a global neurostimulation industry projected to hit $51 billion by 2030. Labeling up to 60% of psychiatric patients as "resistant" creates a false pretext for experimental interventions.[4] Meanwhile, 25% of patients develop psychotropic drug tolerance within weeks, prompting ever-riskier "solutions."[5]
Electroshock: Psychiatry's Recycled Blunder
ECT involves sending up to 460 volts through the brain to trigger seizures. Contrary to PR spin, Eastgate says, experts report modern ECT is no safer—voltage levels are higher than when broken bones were common due to convulsions.
- FDA Loophole: Grandfathered in without clinical trials in 1976. In 2018, the FDA reclassified some ECT uses as "low risk," even for children as young as 13. Over 2,400 public comments opposed this.
- Global Condemnation: The World Health Organization and United Nations consider ECT on children or the non-consenting a form of torture.[6]
- Medical Harm: Neurologists equate ECT's effects to traumatic brain injury.[7] Patients are 44 times more likely to die by suicide than the general population. One in 15 ECT patients face life-threatening cardiac issues.[8]
- Financial Cost: A $3–5.4 billion industry. Medicaid spent $9 million on ECT in 2023 in 27 states.[9] The VA and Department of Defense have administered it to veterans and children under age five.[10]
Deep Brain Stimulation: Electrodes are surgically implanted into the brain, powered by a device in the chest.
- FDA Fast Track: Approved via Humanitarian Device Exemption for OCD in 2009 without efficacy data.
- Harms: Stroke, hemorrhage, hallucinations, sexual dysfunction, apathy, and suicide attempts.[11]
- Patient Testimonies: Participants in failed DBS trials report cognitive decline and emotional deterioration.[12]
Vagus Nerve Stimulation: Electrical stimulation delivered via electrodes wrapped around the vagus nerve.
- FDA: Approved in 2005 for "treatment-resistant depression" despite lacking robust evidence.
- Risks: Nerve damage, infection, hoarseness, breathing difficulty. The FDA has logged over 10,000 complaints involving death, injury, or device malfunction.[13]
- Cost: Averaging $30,000+.
Transcranial Magnetic Stimulation: Magnetic pulses are aimed at the brain over six weeks.
- Youth Approval: Cleared in 2008 for adults, and in 2024 for adolescents as young as 15.
- Side Effects: "Brain fog," seizures, mood swings. One patient said: "This treatment destroyed my life… It gave me false hope."[14]
- Price Tag: Up to $300 per session; full courses can reach $15,000.
Despite the sophistication of these procedures, there is still no objective medical test to diagnose any psychiatric disorder. No blood test. No brain scan. No biomarker.[15]
More on ncarol.com
- J&J Exterminating Mourns the Passing of Founder Bobby John Sr
- Delirious Comedy Club Transforms Into Las Vegas' Newest Live Comedy Studio With Weekly Delirious TV Tapings
- BitTitan Advances MigrationWiz with New Capabilities, Platform Enhancements, and Product Leadership Update
- Sara Abbas Receives "Eniochos" Charioteer Award at 2026 Who is Who International Awards
- Detained at 95: South Korea's Prosecution of a Religious Leader Draws International Alarm
Dr. Thomas Insel, former director of the National Institute for Mental Health advised: "Unlike our definitions of ischemic heart disease, lymphoma, or AIDS, the DSM [Diagnostic and Statistical Manual of Mental Disorders] diagnoses are based on a consensus… not any objective laboratory measure."[16]
"It's not the patient that's resistant—it's the system that's resistant to accountability," Eastgate said. "In any other field, if the intervention failed, the treatment would be reevaluated. But psychiatry doubles down, pushing more dangerous interventions instead."
CCHR urges policy makers to: End all use of ECT and brain stimulation devices for treatment of mental issues, and end ECT's role as a predicate device for newer technologies. And support humane, non-invasive, non-drug, non-brain stimulation solutions that respect patient dignity and avoid neurological and other physical harm.
CCHR, established in 1969 by the Church of Scientology and psychiatrist Dr. Thomas Szasz has a record of reforms that include banning lethal Deep Sleep Treatment, outlawing ECT use on children in several U.S. states, and securing global recognition for patient rights. Today, the United Nations and WHO echo what CCHR has long fought for: coercion has no place in mental health care.
Sources:
[1] FDA, Final Rule on Electroconvulsive Therapy Devices, Federal Register, Dec. 26, 2018; WHO-OHCHR, "Guidance on Mental Health, Human Rights and Legislation," 9 Oct. 2023, p. 58, www.ohchr.org/sites/default/files/documents/publications/WHO-OHCHR-Mental-health-human-rights-and-legislation_web.pdf
[2] Lavanya P. Sharma, et. al, "Deep brain stimulation – A primer for psychiatrists," Asian Journal of Psychiatry, Vol. 104, Feb. 2025
[3] Lavanya P. Sharma, et. al, "Deep brain stimulation – A primer for psychiatrists," Asian Journal of Psychiatry, Vol. 104, Feb. 2025
[4] "Treatment resistance in psychiatry: state of the art and new directions," Mol Psychiatry, July 2021, pmc.ncbi.nlm.nih.gov/articles/PMC8960394/#fn-group1
[5] pmc.ncbi.nlm.nih.gov/articles/PMC9332474/
[6] WHO- OHCHR, "Guidance on Mental Health, Human Rights and Legislation," 9 Oct. 2023, pp. 15, 58 and 59; www.cchrint.org/2023/09/18/who-guideline-condemns-coercive-psychiatric-practices/
[7] "Electroconvulsive Shock Therapy Lawsuit – What You Should Know About ECT," www.wisnerbaum.com/defective-medical-device-injuries/ect/
[8] www.cchrint.org/2024/11/08/veterans-day-cchr-calls-for-safeguards/, Peter Simons, "ECT Does Not Seem to Prevent Suicide," Mad In America, 17 Feb. 2023, www.madinamerica.com/2023/02/ect-does-not-seem-to-prevent-suicide/
More on ncarol.com
- New from Regal House Publishing, The Withers, a desperate fight to defend loved ones
- CCHR: DOJ Takedown Exposes Over $220 Million Defrauded in Behavioral Mental Health Fraud Schemes
- Lady Liberty Is Coming Home: Historic WWII A-26 Invader Begins Her Final Journey to the Tulsa Air & Space Museum
- The Lashe Announces Limited-Time Sale on Professional Premade Fan Lash Extension Trays
- PropAccount.com Adds Prediction Markets to Its Multi-Asset Prop Firm Platform
[9] www.cchrint.org/2024/08/23/the-collapse-of-electroshock/ Based on Freedom of Information Requests to 27 states
[10] www.cchrint.org/2018/10/12/veterans-get-damaging-mental-health-deal/; Tricare Encounter Data (TED) Non-Institutional (Outpatient) for Purchased Care claims, Data Extract as of 10/21/2016, Data received from CCHR International Freedom of Information Request, 2016
[11] "Brain Stimulation Therapies," NIMH, www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies.shtml, accessed 21 Feb. 2011; Dr. Ananya Mandal, MD, "Deep Brain Stimulation Side Effects," News Medical Life Sciences, 22 July 2023, www.news-medical.net/health/Deep-Brain-Stimulation-Side-Effects.aspx
[12] Danielle Egan, "Adverse Effects: The Perils of Deep Brain Stimulation for Depression," Mad in America, 24 Sept. 2015
[13] www.hg.org/legal-articles/patients-with-complications-from-cyberonics-vns-therapy-systems-may-qualify-to-file-a-lawsuit-49467
[14] FDA MAUDE report, Neurostar TMS, 07/14/2021, www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/detail.cfm?mdrfoi__id=15283600&pc=OBP
[15] www.sciencedaily.com/releases/2020/08/200817104247.htm
[16] psychrights.org/2013/130429NIMHTransformingDiagnosis.htm
Source: Citizens Commission on Human Rights International
Filed Under: Health
0 Comments
Latest on ncarol.com
- OneVizion Names AI Leader Matthew Kirk as Chief Operating Officer to Drive Governed AI Across Telecom and Electric Utilities
- Dentists launch independent platform to help practices choose the right technology
- Contracting Resources Group Recognized by The Daily Record as a 2026 In the Lead: Best Women-Owned Businesses Honoree
- Woodforest Acceptance Solutions and AlpacaBOSS Launch Partnership
- New "Lakeside Picnic Ride" Package in Japan's Lake Chuzenji region of Nikko: July 1- November 30, 2026
- Former MP Shri GV Harsha Kumar Meets AICC President Mallikarjun Kharge
- Two Attorneys at The Stanley Law Group Named to 2026 South Carolina Super Lawyers List
- IGH Naturals Announces Peer-Reviewed HuMOLYTE® Study Published in Frontiers in Nutrition
- Allstream Energy Partners Expands AI-Optimized Website Development Division to Meet Growing Demand in GEO / AEO Services
- America's Workforce Solution Named an OpenAI SMB Channel Partner, Bringing Enterprise-Grade AI to Main Street
- Data Tiles Introduces the Decision-Driven Enterprise to North America
- FitTrace Sync 1.11 Brings Apple Health and Google Health Connect Integration Into Its Mobile App
- Disruptor Creations Pioneers New MicroAdventure Series with TravelSpike
- eCopier Solutions Surpasses 3,000 Five-Star Google Reviews and Maintains Perfect Five-Star Rating
- Creative Investment Research Welcomes Supreme Court Decision Protecting Federal Reserve Independence While Calling for Continued Accountability
- New from Regal House Publishing, The Reel Life of Zara Kegg: Love, grief, Godzilla, odd beach winter
- Ascent Solar Technologies (N A S D A Q: ASTI): Positioned at the Intersection of the New Space Economy, Defense Innovation and Next-Generation Energy
- Triple-Digit Growth, Stock Market Upgrade plus a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation (Stock Symbol: CDIX)
- Morrisville & Cary Education Centers Honored with National Award
- AI-Powered Neuropsychiatry, FDA Regulatory Momentum, Commercial Ketamine Launch Position NRx Pharmaceuticals for Potential Breakout Growth in 2026
